Antithrombin III is probably not a suitable biomarker for diagnosis of primary central nervous system lymphoma

Antithrombin III (AT III) in cerebrospinal fluid (CSF) has been suggested to have high specificity and sensitivity in separating primary central nervous system (CNS) lymphoma from other neurological conditions. We measured with ELISA CSF and serum AT III and albumin levels in 12 lymphoma patients wi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Hematol
Main Authors: Kuusisto, Milla Elvi Linnea, Haapasaari, Kirsi-Maria, Remes, Anne Marja, Bloigu, Risto, Karihtala, Peeter, Turpeenniemi-Hujanen, Taina, Kuittinen, Outi
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2015
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4432105/
https://ncbi.nlm.nih.gov/pubmed/25697593
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-015-2334-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados